Changing of HCV Clade Pattern in Iran; the Possible Means for Something Good

authors:

avatar Muhammad Sohail Afzal 1 , * , avatar Sadia Anjum 1 , avatar Najam us Sahar Sadaf Zaidi 1

Atta ur Rahman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan

how to cite: Afzal M S, Anjum S, Zaidi N U S S. Changing of HCV Clade Pattern in Iran; the Possible Means for Something Good. Hepat Mon. 2014;14(1):e11879. https://doi.org/10.5812/hepatmon.11879.

Acknowledgements

References

  • 1.

    Anjum S, Ali S, Ahmad T, Afzal MS, Waheed Y, Shafi T, et al. Sequence and structural analysis of 3' untranslated region of hepatitis C virus, genotype 3a, from pakistani isolates. Hepat Mon. 2013;13(5). ee8390. [PubMed ID: 23922562]. https://doi.org/10.5812/hepatmon.8390.

  • 2.

    Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon. 2013;13(3). ee7723. [PubMed ID: 23745128]. https://doi.org/10.5812/hepatmon.7723.

  • 3.

    Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013;13(1). ee7991. [PubMed ID: 23550108]. https://doi.org/10.5812/hepatmon.7991.

  • 4.

    Waheed Y, Saeed U, Anjum S, Afzal MS, Ashraf M. Development of Global Consensus Sequence and Analysis of Highly Conserved Domains of the HCV NS5B Prote in. Hepat Mon. 2012;12(9). ee6142. [PubMed ID: 23087757]. https://doi.org/10.5812/hepatmon.6142.

  • 5.

    Al-Kubaisy WA, Niazi AD, Kubba K. History of miscarriage as a risk factor for hepatitis C virus infection in pregnant Iraqi women. East Mediterr Health J. 2002;8(2-3):239-44. [PubMed ID: 15339110].

  • 6.

    Aktas E, Ogedey ED, Kulah C, Begendik Comert F. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey]. Mikrobiyol Bul. 2010;44(4):647-50. [PubMed ID: 21063977].

  • 7.

    Afzal MS. Comparison of HCV prevalence in Pakistan and Iran, An Insight into Future. Hepat Mon. 2013;13(12):[Epub ehead of print].

  • 8.

    Kim HI, Kim IH, Jeon BJ, Lee S, Kim SH, Kim SW, et al. Treatment Response and Tolerability of Pegylated Interferon-alpha Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea. Hepat Mon. 2012;12(7):430-6. [PubMed ID: 23008722]. https://doi.org/10.5812/hepatmon.6170.